Cytokinetics, Incorporated (BIT:1CYTK)
Italy
· Delayed Price · Currency is EUR 31.80
-5.20 (-14.05%)
At close: May 2, 2025
Cytokinetics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -589.53 | -526.24 | -388.96 | -215.31 | -127.29 | Upgrade
|
| Depreciation & Amortization | 9.53 | 11.89 | 5.81 | 2.28 | 1.83 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.05 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 2.84 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.02 | 0.04 | 0.11 | - | -0.57 | Upgrade
|
| Stock-Based Compensation | 97.84 | 72.07 | 47.85 | 26.83 | 17.62 | Upgrade
|
| Other Operating Activities | 50.58 | 24.83 | 60.37 | 32.38 | 32.46 | Upgrade
|
| Change in Accounts Receivable | -15.37 | -1.14 | 56.67 | -47.4 | 0.74 | Upgrade
|
| Change in Accounts Payable | -4.48 | -3.48 | 4.52 | 1.06 | -0.11 | Upgrade
|
| Change in Unearned Revenue | 52.37 | - | -87 | - | 87 | Upgrade
|
| Change in Other Net Operating Assets | 3.14 | 7.71 | 1.1 | 54.8 | -2.74 | Upgrade
|
| Operating Cash Flow | -395.89 | -414.33 | -299.52 | -142.52 | 8.94 | Upgrade
|
| Capital Expenditures | -3.91 | -1.42 | -11.34 | -48.87 | -11.05 | Upgrade
|
| Investment in Securities | -549.19 | 240.67 | -250.8 | -98.91 | -185.46 | Upgrade
|
| Investing Cash Flow | -553.1 | 239.25 | -262.13 | -147.78 | -196.52 | Upgrade
|
| Long-Term Debt Issued | - | - | 523.59 | - | - | Upgrade
|
| Long-Term Debt Repaid | -9.62 | -0.86 | -188.93 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -9.62 | -0.86 | 334.66 | - | - | Upgrade
|
| Issuance of Common Stock | 759.86 | 182.69 | 17.54 | 324.85 | 234.23 | Upgrade
|
| Repurchase of Common Stock | -19.63 | -10.52 | -9.6 | -4.87 | -2.26 | Upgrade
|
| Other Financing Activities | 200 | 50 | 173.56 | - | 2.15 | Upgrade
|
| Financing Cash Flow | 930.61 | 221.32 | 516.17 | 319.98 | 234.12 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.21 | -0.02 | - | - | - | Upgrade
|
| Net Cash Flow | -18.17 | 46.22 | -45.48 | 29.68 | 46.55 | Upgrade
|
| Free Cash Flow | -399.8 | -415.75 | -310.85 | -191.39 | -2.11 | Upgrade
|
| Free Cash Flow Margin | -2164.10% | -5521.23% | -328.64% | -271.76% | -3.78% | Upgrade
|
| Free Cash Flow Per Share | -3.57 | -4.31 | -3.46 | -2.49 | -0.03 | Upgrade
|
| Cash Interest Paid | 25.97 | 10.3 | 15.17 | 9.18 | 9.62 | Upgrade
|
| Levered Free Cash Flow | -241.49 | -260.37 | -127.01 | -179.83 | -69 | Upgrade
|
| Unlevered Free Cash Flow | -187.42 | -224.33 | -95.04 | -161.5 | -44.83 | Upgrade
|
| Change in Net Working Capital | -44.27 | -3.26 | -65.26 | 25.29 | -5.49 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.